首页>
外国专利>
BRCA1-based breast or ovarian cancer treatment agents and methods of use
BRCA1-based breast or ovarian cancer treatment agents and methods of use
展开▼
机译:基于BRCA1的乳腺癌或卵巢癌治疗剂及其使用方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A pharmaceutical composition for use in treating, inhibiting, and/or preventing breast and/or ovarian cancer can include: a molecule having a structure of one of Compounds 1-38, pharmaceutically acceptable salt thereof, or analog thereof; and a pharmaceutically acceptable carrier containing the compound. The pharmaceutically acceptable carrier can be configured for oral, systemic, transdermal, intranasal, suppository, parenteral, intramuscular, intravenous, or subcutaneous administration. The compound can be present in the composition in a therapeutically effective amount for treating, inhibiting, and/or preventing breast and/or ovarian cancer. Also, the compound can be present in a therapeutically effective amount for enhancing production of BRCA1.
展开▼